The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Researchers have never seen anything as close to a potential HIV cure as this new nanoparticle approach. As study authors ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Michigan public health leaders and research scientists say the fallout from Trump administration cuts to federal research ...

Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in ...

A research team in Australia has announced what they believe is a breakthrough in the search for an HIV cure. What makes HIV ...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...

Aid organizations have been in talks about taking control of the contraceptives and HIV prevention medication, but those negotiations have stalled amid shifting directives from the government, a Post ...

Davao Region now ranks fourth in national HIV cases, with 306 new cases from Jan-March 2025, primarily among youth. Despite ...